Innate Pharma S.A.
$2.12
-0.05 (-2.30%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +23.3%
- 3 Months
- +16.5%
- YTD
- +21.1%
- 1 Year
- -1.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 98.5%
- Largest decline max drawdown, since Aug 2025
- -50.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.40
Own IPHA?
See how IPHA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.